Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Prevention of AKI in Aortic Surgery
NCT02607163Completed
- Sponsor
- Yonsei University
- Start
- Sep 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Yonsei University. Primary endpoint: Acute Kidney Injury at 7 days. Started Sep 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02607163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607163.